AI-Powered Pet Consultation and Medication Closed-Loop Platform
1) Online consultations: Pay-per-use or subscription-based membership; 2) Commission on medication and supplements: Reve
Key Fields
FIELD STAMPS📌 Background
In 2026, pet medical large models entered the stage of syndrome differentiation and treatment: Wangmiao Lingling released Baimo Mojun V4.0, increasing overall diagnostic accuracy to 92% with over 2 million platform users and a RAG semantic retrieval precision improvement of over 15% compared to the previous generation. Meanwhile, Chongzhiling has built a knowledge graph using over 68 million pet medical records, driving online consultations toward a closed-loop of evidence-based medication. Industry research indicates that China's pet economy exceeded 811.4 billion yuan in 2025, with pet healthcare leading the market at a CAGR of 22.2%.
👤 Target Customers
Pet owners and veterinary clinics; users pay for consultations, while clinics pay for AI-assisted diagnostic tools.
💰 Revenue Streams
1) Online consultations: Pay-per-use or subscription-based membership; 2) Commission on medication and supplements: Revenue share based on transaction volume; 3) System licensing: Licensing fees charged to veterinary clinics for AI-assisted diagnosis and medication recommendation systems; 4) Insurance partnerships: Fees based on collaborative projects with insurers (an opportunity with currently unquantified revenue potential).
🧮 Cost Structure
Large model training and computing power costs, veterinary expert team labor, medical knowledge base maintenance, and platform operations and customer acquisition costs.
🛡️ Moat
Big data in pet healthcare and a knowledge graph for syndrome differentiation and treatment, multi-round clinical data feedback to refine models, and a first-mover advantage in establishing a precise medication closed-loop.
🔑 Keys to Success
- Continuously iterate the clinical accuracy of the syndrome differentiation and treatment model
- Integrate the full chain of consultation, testing, medication, and insurance
- Establish data and channel partnerships with leading veterinary clinics
⚠️ Risks
- Reputational risk due to pet injury or death caused by AI misdiagnosis
- Stricter medical data privacy and compliance reviews
- Pricing pressure caused by subsidy wars from large platforms
🏢 Cases
- Wangmiao Lingling
- Chongzhiling
📊 SWOT Analysis
Strengths
- 92% AI diagnostic accuracy supports user trust
- One-stop closed-loop from consultation to medication increases average transaction value
Weaknesses
- Online consultations cannot replace physical examinations such as palpation and imaging
- Model training relies on high-quality pet medical history data, which is costly to acquire
Opportunities
- Growing demand from pet owners for convenient consultations and medical insurance services
- Potential to build an ecosystem of medical testing, medication, and insurance with offline clinics, chains, and insurance companies
Threats
- Medical disputes and regulatory risks arising from misdiagnosis
- Large platforms like JD.com squeezing vertical players with one-stop medical, testing, and pharmacy solutions